Laparoscopic resection of gastrointestinal neuroendocrine tumors with special contribution of radionuclide imaging

World J Gastroenterol. 2014 Nov 14;20(42):15608-15. doi: 10.3748/wjg.v20.i42.15608.

Abstract

The surgical treatment of neuroendocrine tumors (NETs) draws on experience and guidelines more than on prospective randomized trials. The incidence of NET is increasing in all parts of the gastrointestinal tract. A variety of classifications introduced over the last decade may have led to difficulties in judging clinical relevance and determining the right surgical strategy. The North American Neuroendocrine Tumor Society and the European Neuroendocrine Tumor Society have developed usable guidelines from the available literature. For more than 20 years laparoscopy has developed as the gold standard for various surgical indications. Nevertheless, few trials have compared open and laparoscopic surgery with regard to NET. This review summarizes the recent literature on surgery for NET and incorporates the evidence on laparoscopy for cancer which might be also applied for NET.

Keywords: Gastrointestinal; Image-guided surgery; Laparoscopy; Neuroendocrine tumors; Somatostatin receptor imaging.

Publication types

  • Review

MeSH terms

  • Digestive System Surgical Procedures / adverse effects
  • Digestive System Surgical Procedures / methods*
  • Gastrointestinal Neoplasms / diagnostic imaging*
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / surgery*
  • Humans
  • Laparoscopy / adverse effects
  • Laparoscopy / methods*
  • Multimodal Imaging
  • Neoplasm Grading
  • Neoplasm Staging
  • Neuroendocrine Tumors / diagnostic imaging*
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / surgery*
  • Predictive Value of Tests
  • Radionuclide Imaging / methods*
  • Surgery, Computer-Assisted / adverse effects
  • Surgery, Computer-Assisted / methods*
  • Treatment Outcome